Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127781711 | 12778171 | 1 | I | 20160915 | 20160925 | 20160925 | EXP | PHHY2016LV128661 | SANDOZ | VINKALNA I, KADIKE S, ALDINS P, LUGOVSKA S. CHRONIC VIRAL HEPATITIS C WITH ACUTE TOXIC HEPATITIS. DOCTUS. 2016;9:44-8 | 60.00 | YR | F | Y | 0.00000 | 20160926 | OT | LV | LV |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127781711 | 12778171 | 1 | PS | ZOLPIDEM TARTRATE. | ZOLPIDEM TARTRATE | 1 | Unknown | 10 MG, PRN | U | 77322 | 10 | MG | FILM-COATED TABLET | ||||||
| 127781711 | 12778171 | 2 | SS | PAROXETINE. | PAROXETINE | 1 | Oral | 20 MG, QD, IN THE EVENING | U | 0 | 20 | MG | TABLET | QD | |||||
| 127781711 | 12778171 | 3 | SS | MELOXICAM. | MELOXICAM | 1 | Intramuscular | 5 MG, QD | U | 0 | 5 | MG | SOLUTION FOR INJECTION | QD | |||||
| 127781711 | 12778171 | 4 | SS | NIMESULIDE | NIMESULIDE | 1 | Oral | 100 MG, TID | U | 0 | 100 | MG | SACHET | TID | |||||
| 127781711 | 12778171 | 5 | SS | IBUPROFEN. | IBUPROFEN | 1 | Oral | 400 MG, TID | U | 0 | 400 | MG | TABLET | TID | |||||
| 127781711 | 12778171 | 6 | SS | NEIROMIDIN | IPIDACRINE | 1 | Oral | 20 MG, BID | U | 0 | 20 | MG | TABLET | BID | |||||
| 127781711 | 12778171 | 7 | SS | MELDONIUM | MELDONIUM | 1 | Oral | 250 MG, QD | U | 0 | 250 | MG | CAPSULE | QD | |||||
| 127781711 | 12778171 | 8 | SS | VIGANTOL//COLECALCIFEROL | CHOLECALCIFEROL | 1 | Unknown | 5 DRP, QD | U | 0 | 5 | GTT | OIL | QD | |||||
| 127781711 | 12778171 | 9 | SS | MEDROL | METHYLPREDNISOLONE | 1 | Oral | 4 MG, QD | U | 0 | 4 | MG | TABLET | QD | |||||
| 127781711 | 12778171 | 10 | SS | PEGYLATED INTERFERON ALFA-2A | PEGINTERFERON ALFA-2A | 1 | Unknown | D | 0 | ||||||||||
| 127781711 | 12778171 | 11 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Unknown | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127781711 | 12778171 | 1 | Insomnia |
| 127781711 | 12778171 | 2 | Product used for unknown indication |
| 127781711 | 12778171 | 3 | Product used for unknown indication |
| 127781711 | 12778171 | 4 | Product used for unknown indication |
| 127781711 | 12778171 | 5 | Product used for unknown indication |
| 127781711 | 12778171 | 6 | Product used for unknown indication |
| 127781711 | 12778171 | 7 | Product used for unknown indication |
| 127781711 | 12778171 | 8 | Product used for unknown indication |
| 127781711 | 12778171 | 9 | Product used for unknown indication |
| 127781711 | 12778171 | 10 | Hepatitis C |
| 127781711 | 12778171 | 11 | Hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127781711 | 12778171 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127781711 | 12778171 | Cholelithiasis | |
| 127781711 | 12778171 | Coagulopathy | |
| 127781711 | 12778171 | Drug ineffective | |
| 127781711 | 12778171 | Drug-induced liver injury | |
| 127781711 | 12778171 | Fall | |
| 127781711 | 12778171 | Hepatic failure | |
| 127781711 | 12778171 | Insomnia | |
| 127781711 | 12778171 | Polyneuropathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127781711 | 12778171 | 10 | 201509 | 201512 | 0 | |
| 127781711 | 12778171 | 11 | 201509 | 201512 | 0 |